ACADIA Pharmaceuticals
ACAD
#3635
Rank
NZ$6.15 B
Marketcap
NZ$36.11
Share price
-3.35%
Change (1 day)
20.48%
Change (1 year)

Earnings for ACADIA Pharmaceuticals (ACAD)

Earnings in 2025 (TTM): NZ$0.23 Billion

According to ACADIA Pharmaceuticals's latest financial reports the company's current earnings are NZ$1.07 Billion. a decrease over its 2024 earnings that were of NZ$0.44 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for ACADIA Pharmaceuticals from 2003 to 2025

Annual earnings

Year Earnings Change
2025 NZ$0.24 B-46.18%
2024 NZ$0.44 B-605.67%
2023 -NZ$88.81 Million-76.09%
2022 -NZ$0.38 Billion27.41%
2021 -NZ$0.3 Billion-40.38%
2020 -NZ$0.49 Billion19.88%
2019 -NZ$0.41 Billion-3.92%
2018 -NZ$0.43 Billion-15.04%
2017 -NZ$0.5 Billion6.33%
2016 -NZ$0.47 Billion64.55%
2015 -NZ$0.29 Billion77.47%
2014 -NZ$0.17 Billion143.69%
2013 -NZ$66.03 Million81.93%
2012 -NZ$36.3 Million-8.73%
2011 -NZ$39.77 Million-251.39%
2010 NZ$26.26 M-133.2%
2009 -NZ$79.12 Million-30.82%
2008 -NZ$0.12 Billion6.43%
2007 -NZ$0.11 Billion25.89%
2006 -NZ$85.36 Million36.99%
2005 -NZ$62.31 Million37.22%
2004 -NZ$45.41 Million19.96%
2003 -NZ$37.85 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$58.38 B 24,054.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$17.73 B 7,237.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$44.77 B 18,424.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$16.23 B 6,615.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Vanda Pharmaceuticals
VNDA
-NZ$0.22 Billion-187.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Adamas Pharmaceuticals
ADMS
-NZ$67.22 Million-127.81%๐Ÿ‡บ๐Ÿ‡ธ USA